Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Research

The effectiveness of enhanced cognitive behavioural therapy for eating disorders: An open trial

The aim of this study was to examine the effectiveness of Enhanced Cognitive Behaviour Therapy (CBT-E) for eating disorders in an open trial for adults...

Research

Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma-Which is best

Blood-based markers for malignant mesothelioma (MM), particularly soluble mesothelin and osteopontin, are currently of great clinical interest.

Research

Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis

Early detection of the cyanobacterium Pseudomonas aeruginosa in the lungs of young children with cystic fibrosis (CF) is considered the key to delaying...

News & Events

Cheers as Beau’s curls cut to fund cancer fight

A brave young man stepped up to the plate on Friday to do his part in the battle against cancer.

News & Events

Celebrating CONNECT

At The Kids Research Institute Australia, we’ve always known what a fantastic community we have around us.

News & Events

Be on alert for meningitis

The Meningitis Centre is urging all people to be on alert for the signs and symptoms of the potential deadly disease.

News & Events

Aboriginal researcher NAIDOC Person of the Year

The head of Indigenous research at Perth's The Kids for Child Health Research has been honoured as the 2008 National NAIDOC Person of the Year.

News & Events

Preventing suicide - what can you do?

A new information pack is now available to help anyone who is concerned about a friend or family member who is distressed or suicidal.

News & Events

New action on alcohol and pregnancy

Doctors and other health professionals who care for pregnant women are being encouraged to talk openly to women about the dangers of alcohol in pregnancy.

News & Events

Potential new vaccine for WA's meningococcal threat

Perth researchers are about to trial a new vaccine that could potentially provide protection against the most common form of meningococcal